| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/07/2004 | US6787321 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 09/07/2004 | US6787154 Artificial antigen presenting cells |
| 09/07/2004 | US6787141 Peptide having for fibrinogen fragment E activity, analogs, antibodies and uses thereof |
| 09/07/2004 | US6787137 Campylobacter vaccine |
| 09/07/2004 | CA2248651C Method of identifying mhc-class i restriced antigens endogenously processed by a cellular secretory pathway |
| 09/07/2004 | CA2173594C Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
| 09/02/2004 | WO2004074497A2 Endomannosidases in the modification of glycoproteins in eukaryotes |
| 09/02/2004 | WO2004074489A1 Method of forming bone/cartilage tissue with use of fat cell |
| 09/02/2004 | WO2004074466A1 Novel cell line, preparation method thereof and use of same, particularly for monitoring changes in chromatin texture |
| 09/02/2004 | WO2004074465A1 Human salivary gland-origin stem cell |
| 09/02/2004 | WO2004074464A1 Generating teeth from bone marrow cells |
| 09/02/2004 | WO2004074463A1 Hydrogel for cell separation and method of separating cells |
| 09/02/2004 | WO2004074457A2 Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| 09/02/2004 | WO2004074451A2 Loading of cells with antigens by electroporation |
| 09/02/2004 | WO2004074445A2 Model for studying the role of genes in tumor resistance to chemotherapy |
| 09/02/2004 | WO2004074439A2 An expression cassette and vector for transient or stable expression of exogenous molecules |
| 09/02/2004 | WO2004074435A2 Methods for identifying and administering agents that bias the immune response via dendritic cells |
| 09/02/2004 | WO2004074325A2 Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers |
| 09/02/2004 | WO2004073843A1 Composite materials comprising supported porous gels |
| 09/02/2004 | WO2004073761A1 Endothelial cell sheet for cornea regeneration, method of producing the same and method of using the same |
| 09/02/2004 | WO2004073633A2 Methods and compositions for modulating the development of stem cells |
| 09/02/2004 | WO2004073624A2 Contraceptive methods and compositions related to proteasomal interference |
| 09/02/2004 | WO2004073609A2 Posh associated kinases and related methods |
| 09/02/2004 | WO2004062559A3 Use of microcapsules comprising an antigen for the manufacture of an ex-vivo medicament to initiate an immune response |
| 09/02/2004 | WO2004061091A3 Insulin producing cells |
| 09/02/2004 | WO2004032881A3 Implantation of encapsulated biological materials for treating diseases |
| 09/02/2004 | WO2004027040A3 Devices and methods for isolating and recovering target cells |
| 09/02/2004 | WO2004024084A3 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 09/02/2004 | WO2004018655A3 Method for culturing stem cells |
| 09/02/2004 | WO2004016212A3 Methods and compositions for targeting secretory lysosomes |
| 09/02/2004 | WO2003104439A3 Assay device that analyzes the absorption, metabolism, permeability and/or toxicity of a candidate compound |
| 09/02/2004 | WO2003020915A3 Non-linear amplitude dielectrophoresis waveform for cell fusion |
| 09/02/2004 | US20040172683 Comprises cocoa flavor peptides for improving the preparation of cocoa flavor and cocoa flavor substitutes; food processing and flavor enhancement |
| 09/02/2004 | US20040172679 Monocotyledon plant cells and plants which synthesise modified starch |
| 09/02/2004 | US20040172675 using a D-specific enoyl-CoA hydratase gene in genetically engineered klebsiella, aeromonas, clostridium, and escherichia |
| 09/02/2004 | US20040172673 Expression vector comprising nucleotide sequences coding polypetide which confers resistance to pseudomonas syringae; genetic engineering and disease resistant plants |
| 09/02/2004 | US20040172670 Maize yellow stripe1 and related genes |
| 09/02/2004 | US20040171826 Endomannosidases in the modification of glycoproteins in eukaryotes |
| 09/02/2004 | US20040171811 for drug screening using animal models with in vitro activation; genetic engineering |
| 09/02/2004 | US20040171807 involves engineering a recombinant shuttle vector comprising a nucleic acid cassette encoding prokaryotic green fluorescent protein (GFP) operably linked to regulatory sequences which permit its expression in a host cell |
| 09/02/2004 | US20040171806 Modified hpv e6 and e7 genes and proteins useful for vaccination |
| 09/02/2004 | US20040171804 for drug screening cancer, osteoporosis, obesity, Alzheimer's disease drugs; genetic engineering; kits |
| 09/02/2004 | US20040171803 Artificial protein having potentiated immunogenicity of epitope |
| 09/02/2004 | US20040171802 Haemophilus influenzae antigens and corresponding dna fragments |
| 09/02/2004 | US20040171801 Nk-2 homeobox transcription factor |
| 09/02/2004 | US20040171800 Gamma retinoic acid receptor |
| 09/02/2004 | US20040171569 that directs formation of a recombinant virus upon introduction into a cell |
| 09/02/2004 | US20040171559 stem cells require extracellular wnt signaling for proliferation and thus are rendered quiescent by administration of agents that block extracellular wnt signaling |
| 09/02/2004 | US20040171551 which binds to an amino acid sequence comprising at least 5 EP motifs over a 19 amino acid segment |
| 09/02/2004 | US20040171546 Regulation of lung tissue by hedgehog-like polypeptides and formulations and uses related thereto |
| 09/02/2004 | US20040171538 Anticoagulants and their uses |
| 09/02/2004 | US20040171533 Methods and compositions for regulating adiopocytes |
| 09/02/2004 | US20040171153 Stem cell |
| 09/02/2004 | US20040171152 Animal cell culture media comprising non-animal or plant-derived nutrients |
| 09/02/2004 | US20040171151 Method for preparing a cartilaginous neo-tissue |
| 09/02/2004 | US20040171148 Cell preparations comprising cells of the T cell lineage and methods of making and using them |
| 09/02/2004 | US20040171147 Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| 09/02/2004 | US20040171146 Adipose-derived stem cells and lattices |
| 09/02/2004 | US20040171145 Artificial dermis and production method therefor |
| 09/02/2004 | US20040171144 Increasing sperm motility |
| 09/02/2004 | US20040171123 fusion protein of an antibody that binds to human epidermal growth factor receptor-2 (HER2) and albumin with long shelf-life; stabilizing therapeutic proteins such as antibodies by conjugating them to albumin |
| 09/02/2004 | US20040171122 Gm-csf and/or defensin protein expression regulators in epithelial cells comprising ets transcription factor or gene encoding the same |
| 09/02/2004 | US20040171120 Enhanced insecticidal protein for killing bettles, moths, flies; biolgical pest control |
| 09/02/2004 | US20040171117 Anti-RANK ligand monoclonal antibodies useful in treatment of RANK ligand mediated disorders |
| 09/02/2004 | US20040171113 Antigens of group b streptococcus and corresponding dna fragments |
| 09/02/2004 | US20040171112 Used to determine the redox status within a cell for example; mutant has cysteine at specified positions |
| 09/02/2004 | US20040171111 Polypeptide of a p53 protein-specific murin a/t-cell receptor, nucleic acids coding therefor and use thereof |
| 09/02/2004 | US20040171110 Novel member of the lysyl oxidase gene family |
| 09/02/2004 | US20040171108 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 09/02/2004 | US20040171107 Modified flourescent proteins |
| 09/02/2004 | US20040171104 may be used in food related applications to improve flavor, such as baking; genetic engineering |
| 09/02/2004 | US20040171090 Screening for cytotoxic t-lymphocyte recognition antigen associated with human t-cell leukemia virus infected cells for diagnosing and prognosing inflammation and cell proliferation disorders |
| 09/02/2004 | US20040171046 Method for monitoring the transition of a cell from one state into another |
| 09/02/2004 | US20040171045 Assay for predicting cell activity |
| 09/02/2004 | US20040171042 Functional assays that use theT1R1 receptor to screen for T1R1-associated taste modulators |
| 09/02/2004 | US20040171018 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 09/02/2004 | US20040171015 Cyp450-specific dna probes and primers, and biological applications thereof |
| 09/02/2004 | US20040171012 Nucleic acid-associated proteins |
| 09/02/2004 | US20040171005 Codon-optimised nucleic acid coding for apoaequorin and uses thereof |
| 09/02/2004 | US20040170999 Nuclear hormone receptor ligand binding domain |
| 09/02/2004 | US20040170995 for drug screening in vitro for mitogen-activated protein kinase-activated protein kinase-2 modulators using expression libraries; genetic engineering; kits |
| 09/02/2004 | US20040170993 Methods for diagnosing and treating heart disease |
| 09/02/2004 | US20040170979 Dna encoding l-ribose isomerase and uses thereof |
| 09/02/2004 | US20040170974 for drug screening treatments for asthma/inflammatory disorders; genetic engineering; kits |
| 09/02/2004 | US20040170973 DNA encoding the human serine protease EOS |
| 09/02/2004 | US20040170969 GRF2 binding proteins and applications thereof |
| 09/02/2004 | US20040170965 Mixed cell diagnostic systems |
| 09/02/2004 | US20040170964 Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces |
| 09/02/2004 | US20040170961 for drug screening anticancer agents; solid phase synthesis; animal models; genetic engineering; kits |
| 09/02/2004 | US20040170953 comprises using a phosphate buffer that specifically binds to hepatitis B virus; genetic engineering; kits |
| 09/02/2004 | US20040170705 Compositions and methods for non-insulin glucose uptake |
| 09/02/2004 | US20040170663 Priming extracellular matrix by treating with a priming agent; adding to the primed extracellular matrix a solution of a polymerizable agent; reacting the primed extracellular matrix and polymerizable agent to create a hydrogel covalently bound to the extracellular matrix |
| 09/02/2004 | US20040170653 recognised by CD8-positive cytotoxic T-lymphocytes as a peptide antigen and causes a CTL-induced lysis and/or apoptosis of tumor or leukemia cell; has the amino acid sequence LLGDLFGV, which corresponds to the amino acid positions 81 to 88 of the hdm2 proto-oncoprotein |
| 09/02/2004 | US20040170644 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof |
| 09/02/2004 | US20040170624 active principle, especially the humanized monoclonal antibody JAQ1, that induces irreversible inactivation or degradation of the collagen receptor on thrombocytes; diagnostic agent for the determination of the expression rate of the collagen receptor GPVI |
| 09/02/2004 | US20040170621 inhibiting eosinophil chemotactic factor-L expression or activity by means including use of anti-ECF-L antibody, antisense S-oligonucleotide to ECF-L, mECF-L polyclonal antisera, rabbit preimmune antisera, OPG RANK-Fc or by inhibiting osteoclast formation; also administering mECF-L with RANKL |
| 09/02/2004 | US20040170616 transferring a gene to preselected vertebrate cells by accelerating microprojectiles carrying polynucleic acid sequences having a regulatory sequence in the 5' to 3' direction and a gene downstream from the sequence at the cells to penetrate them and deposit the polynucleic acid sequences therein. |
| 09/02/2004 | US20040170614 Somatic cell gene targeting vectors and methods of use thereof |
| 09/02/2004 | US20040170613 Compositions and methods for liver growth and liver protection |
| 09/02/2004 | US20040170612 Injectable polysaccharide-cell compositions |